Alector, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Alector, Inc. (ALEC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $88.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2022-02-24
- Alector, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was $88.00K, a 72.55% increase from fiscal 2020.
- Alector, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2020 was $51.00K, a 58.87% decline from fiscal 2019.
- Alector, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2019 was $124.00K, a 113.79% increase from fiscal 2018.
- Alector, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2018 was $58.00K, a 53.97% decline from fiscal 2017.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2021-12-31 | $88.00K 10-K · filed 2022-02-24 |
| 2020-12-31 | $51.00K 10-K · filed 2022-02-24 |
| 2019-12-31 | $124.00K 10-K · filed 2022-02-24 |
| 2018-12-31 | $58.00K 10-K · filed 2021-02-25 |
| 2017-12-31 | $126.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |